Effect of 30 mCi radioiodine on multinodular goiter previously treated with recombinant human thyroid-stimulating hormone

Brazilian Journal of Medical and Biological Research

Volumn 40, Issue 12, 2007, Pages 1661-1670

  Paz Filho, G J ^a,e   Mesa Junior, C O ^a   Olandoski, M ^b   Woellner, L C ^c   Goedert, C A ^d   Boguszewski, C I ^a   Carvalho, G A ^a   Graf, H ^a  

^a FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

^b PONTIFICAL CATHOLIC UNIVERSITY OF PARANÁ   (Brazil)

^c Centro de Medicina Nuclear   (Brazil)

^d Centro de Tomografia Computadorizada   (Brazil)

^e NONE   (United States)

Author keywords

131l; Multinodular goiter; Radioiodine; Recombinant TSH; Thyroid

Indexed keywords

IODINE 131; LIOTHYRONINE; RECOMBINANT THYROTROPIN; THIAMAZOLE; THYROGLOBULIN; THYROID ANTIBODY; THYROTROPIN; THYROXINE;

ADULT; AGED; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG SAFETY; FEMALE; FREE LIOTHYRONINE INDEX; FREE THYROXINE INDEX; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; INCIDENCE; IODINE 131 UPTAKE TEST; LOW DRUG DOSE; MALE; MULTINODULAR GOITER; NODULAR GOITER; REVIEW; SINGLE DRUG DOSE; THYROID WEIGHT; THYROIDITIS; TREATMENT DURATION; TREATMENT OUTCOME;

EID: 38349099257     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X2006005000186     Document Type: Review

References (32)

1. Hegedus L, Bonnema SJ, Bennedbaek FN. Management of simple nodular goiter: current status and future perspectives. Endocr Rev 2003; 24: 102-132.
2. Roti E, Uberti ED. Iodine excess and hyperthyroidism. Thyroid 2001; 11: 493-500.
3. Leese GP, Jung RT, Guthrie C, Waugh N, Browning MC. Morbidity in patients on L-thyroxine: a comparison of those with a normal TSH to those with a suppressed TSH. Clin Endocrinol 1992; 37: 500-503.
4. Berghout A, Wiersinga WM, Drexhage HA, Smits NJ, Touber JL. Comparison of placebo with L-thyroxine alone or with carbimazole for treatment of sporadic non-toxic goitre. Lancet 1990; 336: 193-197.
5. Wesche MF, Tiel V, Lips P, Smits NJ, Wiersinga WM. A randomized trial comparing levothyroxine with radioactive iodine in the treatment of sporadic nontoxic goiter. J Clin Endocrinol Metab 2001; 86: 998-1005.
6. Thomusch O, Machens A, Sekulla C, Ukkat J, Lippert H, Gastinger I, et al. Multivariate analysis of risk factors for postoperative complications in benign goiter surgery: prospective multicenter study in Germany. World J Surg 2000; 24: 1335-1341.
7. Bonnema SJ, Bertelsen H, Mortensen J, Andersen PB, Knudsen DU, Bastholt L, et al. The feasibility of high dose iodine 131 treatment as an alternative to surgery in patients with a very large goiter: effect on thyroid function and size and pulmonary function. J Clin Endocrinol Metab 1999; 84: 3636-3641.
8. Kay TW, d'Emden MC, Andrews JT, Martin FI. Treatment of non-toxic multinodular goiter with radioactive iodine. Am J Med 1988; 84: 19-22.
9. Howarth DM, Epstein MT, Thomas PA, Allen LW, Akerman R, Lan L. Outpatient management of patients with large multinodular goitres treated with fractionated radioiodine. Eur J Nucl Med 1997; 24: 1465-1469.
10. 131I therapy in patients with non-toxic multinodular goiter. Eur J Endocrinol 1995; 132: 86-87.
11. Huysmans DA, Hermus AR, Corstens FH, Barentsz JO, Kloppenborg PW. Large, compressive goiters treated with radioiodine. Ann Intern Med 1994; 121; 757-762.
12. Nygaard B, Hegedus L, Gervil M, Hjalgrim H, Soe-Jensen P, Hansen JM. Radioiodine treatment of multinodular non-toxic goitre. BMJ 1993; 307: 828-832.
13. Hegedus L, Hansen BM, Knudsen N, Hansen JM. Reduction of size of thyroid with radioactive iodine in multinodular non-toxic goitre. BMJ 1988; 297: 661-662.
14. Le Moli R, Wesche MF, Tiel-Van Buul MM, Wiersinga WM. Determinants of long term outcome of radioiodine therapy of sporadic non-toxic goitre. Clin Endocrinol 1999; 50: 783-789.
15. Torres MS, Ramirez L, Simkin PH, Braverman LE, Emerson CH. Effect of various doses of recombinant human thyrotropin on the thyroid radioactive iodine uptake and serum levels of thyroid hormones and thyroglobulin in normal subjects. J Clin Endocrinol Metab 2001; 86: 1660-1664.
16. Huysmans DA, Nieuwlaat WA, Erdtsieck RJ, Schellekens AP, Bus JW, Bravenboer B, et al. Administration of a single low dose of recombinant human thyrotropin significantly enhances thyroid radioiodide uptake in nontoxic nodular goiter. J Clin Endocrinol Metab 2000; 85: 3592-3596.
17. Nieuwlaat WA, Hermus AR, Sivro-Prndelj F, Corstens FH, Huysmans DA. Pretreatment with recombinant human TSH changes the regional distribution of radioiodine on thyroid scintigranns of nodular goiters. J Clin Endocrinol Metab 2001; 86: 5330-5336.
18. Nieuwlaat WA, Huysmans DA, van den Bosch HC, Sweep CG, Ross HA, Corstens FH, et al. Pretreatment with a single, low dose of recombinant human thyrotropin allows dose reduction of radioiodine therapy in patients with nodular goiter. J Clin Endocrinol Metab 2003; 88: 3121-3129.
19. Albino CC, Mesa CO Jr, Olandoski M, Ueda CE, Woellner LC, Goadert CA, et al. Recombinant human thyrotropin as adjuvant in the treatment of multinodular goiters with radioiodine. J Clin Endocrinol Metab 2005; 90: 2775-2780.
20. Pacini F, Molinaro E, Castagna MG, Agate L, Elisei R, Ceccarelli C, et al. Recombinant human thyrotropin-stimulated serum thyroglobulin combined with neck ultrasonography has the highest sensitivity in monitoring differentiated thyroid carcinoma. J Clin Endocrinol Metab 2003; 88: 3668-3673.
21. Haugen BR, Pacini F, Reiners C, Schlumberger M, Ladenson PW, Sherman SI, et al. A comparison of recombinant human thyrotropin and thyroid hormone withdrawal for the detection of thyroid remnant or cancer. J Clin Endocrinol Metab 1999; 84: 3877-3885.
22. Nielsen VE, Bonnema SJ, Hegedus L. The effects of recombinant human thyrotropin in normal subjects and patients with goitre. Clin Endocrinol 2004; 61: 655-663.
23. 131I therapy of patients with nodular goiter: an evaluation by a randomized double-blinded trial. J Clin Endocnnol Metab 2005; 90: 79-83.
24. Zelmanovitz F, Zelmanovitz T, Zelmanovitz W. Radioactive iodine 131 treatment of nontoxic multinodular goiter with ambulatory doses. Thyroid 2000; 10: 144 (Abstract).
25. Cardia MS, Rubio IG, Medeiros-Neto G. Prolonged follow-up of multinodular goitre patients treated with radioiodine preceded or not by human recombinant TSH. Clin Endocrinol 2006; 64: 474.
26. Silva MN, Rubio IG, Romeo R, Gebrin EM, Buchpiguel C, Tomimori E, et al. Administration of a single dose of recombinant human thyrotrophin enhances the efficacy of radioiodine treatment of large compressive multinodular goitres. Clin Endocrinol 2004; 60: 300-308.
27. Cohen O, Ilany J, Hoffman C, Olchovsky D, Dabhi S, Karasik A, et al. Low-dose recombinant human thyrotropin-aided radioiodine treatment of large, multinodular goiters in elderly patients. Eur J Endocrinol 2006; 154: 243-252.
28. Nielsen VE, Bonnema SJ, Boel-Jorgensen H, Grupe P, Hegedus L. Stimulation with 0.3-mg recombinant human thyrotropin prior to iodine 131 therapy to improve the size reduction of benign nontoxic nodular goiter: a prospective randomized double-blind trial. Arch Intern Med 2006; 166: 1476-1482.
29. Zelmanovitz F, Genro S, Gross JL. Suppressive therapy with levothyroxine for solitary thyroid nodules: a double-blind controlled clinical study and cumulative meta-analyses. J Clin Endocrinol Metab 1998; 83: 3881-3885.
30. Kogal T, Taki K, Brent CA. Enhancement of sodium/iodide symporter expression in thyroid and breast cancer. Endocr Relat Cancer 2006; 13: 797-826.
31. 131I treatment in patients with nontoxic goiter. J Clin Endocrinol Metab 1997; 82: 2926-2930.
32. Rubio IG, Perone BH, Silva MN, Knobel M, Medeiros-Neto G. Human recombinant TSH preceding a therapeutic dose of radioiodine for multinodular goiters has no significant effect in the surge of TSH-receptor and TPO antibodies. Thyroid 2005; 15: 134-139.